Company: GEHC
Filing Date: 2025-07-30
Form Type: 10-Q
Source: 0001932393-25-000049
Chunk: 53

Company: GE HealthCare Technologies Inc.
Filing Date: 2025-07-30
Form: 10-Q
Item: Item 1
Chunk 53
---
 were as follows:

•USCAN revenues were $4,577 million, growing 6% or $240 million with growth across all segment revenues;

•EMEA revenues were $2,442 million, growing 3% or $62 million largely due to growth in Imaging revenues;

•China region revenues were $1,156 million, decreasing 2% or $24 million with declines in Imaging and AVS revenues partially offset by growth in PDx revenues; and

•Rest of World revenues were $1,609 million, growing 1% or $17 million with growth in PDx revenues, inclusive of NMP revenues, partially offset by unfavorable foreign currency impacts and declines in Imaging revenues.

____________________

*Non-GAAP Financial Measure

33

Table of Contents             

OPERATING INCOME, NET INCOME ATTRIBUTABLE TO GE HEALTHCARE, ADJUSTED EBIT*, AND ADJUSTED NET INCOME*.

For the three months ended June 30For the six months ended June 302025% of Total revenues2024% of Total revenues% change2025% of Total revenues2024% of Total revenues % changeOperating income    $65413.1%$60812.6%8%$1,28313.1%$1,14812.1%12%Net income attributable to GE HealthCare4869.7%4288.9%13%1,04910.7%8028.5%31%Adjusted EBIT*72914.6%74215.3%(2)%1,44314.8%1,42315.0%1%Adjusted net income*4879.7%4599.5%6%9519.7%8729.2%9%

For the three months ended June 30, 2025

Operating income was $654 million, an increase of $46 million and 50 basis points as a percent of Total revenues. The increase was due to the following factors: 

•Gross profit decreased $17 million or 170 basis points as a percent of Total revenues primarily due to an increase in both Cost of products sold and Cost of services sold as a percent of Total revenues. Cost of products sold increased $114 million or 240 basis points as a percent of Sales of products. The increase as a percent of sales was driven primarily by cost inflation, including the impact of incremental tariffs, and investment in design follow-through, partially offset by cost productivity. Cost of